Structural Variant Association for Agricultural Trait Discovery

An SV catalog is not yet a population genotype dataset, and an association peak is not yet a breeding marker. We turn structural-variant catalogs or sequencing data into harmonized population genotypes, test SV effects alongside SNP evidence, and prioritize deletions, insertions, duplications, inversions, and copy-number variants for independent validation and marker conversion.

What This Solution Helps You Decide

Is the SV catalog reusable across the population? Which SVs can be genotyped with the available data? Does an SV add evidence beyond nearby SNPs? Which candidates should enter validation or assay design?
Discuss Your SV Association Project Review Samples & Data Inputs

Structural variant catalog, population genotyping, trait association, and candidate validation evidence chain

Structural Variant Association: What It Does

Structural variants can affect gene content, dosage, regulation, and chromosome structure, but discovery in a few assemblies does not show whether the same event can be called consistently in hundreds of individuals. This Solution begins at that gap: it asks which SV definitions, samples, phenotypes, and evidence types can support a defensible population-level test.

Why SV projects stall after discovery

  • Incompatible event identities: the same biological event may have different coordinates, breakpoints, alleles, or IDs across callers and assemblies.
  • Discovery bias: a catalog built from a few accessions overrepresents variants that were easiest to assemble or detect in those genomes.
  • Uneven callability: repeats, paralogs, low coverage, platform differences, and SV class produce systematic missingness or genotype error.
  • Confounded associations: rare alleles, population structure, relatedness, batch effects, and phenotype imbalance can create unstable signals.
  • Unconvertible candidates: an associated interval may lack a stable breakpoint, assayable sequence, replication evidence, or independence from nearby SNPs.

What this Solution produces

  • A versioned, harmonized SV set with explicit event identities and exclusions.
  • A population genotype matrix for supported DEL, INS, DUP, INV, CNV, or presence/absence events.
  • Callability, frequency, missingness, platform, batch, and subgroup QC evidence.
  • SV-only and combined SNP+SV association results with population controls.
  • A ranked candidate list with validation and marker-conversion recommendations.

If the main goal is to discover SVs or build a species variation resource, begin with Pan-Genome Analysis or Long-Read Sequencing. If the project already has a population-ready SNP set and needs conventional SNP association, use GWAS Services. This page focuses on the additional work required to test SVs as population-level trait candidates.

What We Can Analyze in an SV Association Project

We can start from an existing SV catalog, raw or aligned sequencing data, graph or pangenome evidence, and matched phenotype and population records. The first review determines which deletions, insertions, duplications, inversions, copy-number variants, or presence/absence events can be identified consistently across the cohort.

A reusable catalog must describe an event well enough for the same allele to be recognized in every sample. Before cohort analysis, we audit coordinate systems, breakpoint tolerance, allele sequence, SV class, multi-allelic structure, reference build, discovery source, and evidence available for re-genotyping.

Reference and coordinate identity

We confirm genome build, chromosome naming, reference orientation, liftover history, contig placement, and whether all catalogs describe the same coordinate system.

Breakpoint and allele definition

Exact or interval breakpoints, inserted sequence, orientation, copy state, and flanking context determine whether apparently similar calls represent one event or several alleles.

Discovery and ascertainment context

Source accessions, sequencing platforms, callers, assemblies, coverage, and filtering rules reveal which SV classes and frequency ranges may be over- or underrepresented.

Population re-genotyping evidence

Read pairs, split reads, depth, local assembly, graph paths, long-read support, or assayable junctions are reviewed by event class. An ID without recoverable evidence is not population-ready.

Structural variant records harmonized by genome build, breakpoint, allele sequence, event type, and stable identity

One biological event, one auditable identity

Overlapping calls are not merged solely because their coordinates are close. The consolidation rule reflects SV type, size, breakpoint uncertainty, inserted sequence, reciprocal overlap, orientation, and multi-allelic context. Source records remain traceable to the harmonized event.

  • Retain source caller and assembly provenance.
  • Separate alternate representations from genuinely distinct alleles.
  • Flag ambiguous or nested events instead of forcing a biallelic model.
  • Freeze the event set before association testing.

The first go/no-go decision

Proceed when the candidate events have a defined reference, interpretable alleles, cohort-recoverable evidence, and a traceable harmonization rule. If those conditions are not met, the appropriate next step may be targeted breakpoint refinement, additional long-read discovery, representative assembly work, or a narrower candidate set rather than full-cohort association.

Choose the SV Genotyping and Association Solution That Fits Your Evidence

Projects can reuse a qualified catalog, rebuild and harmonize events from sequencing data, or combine SV and SNP evidence. The route is selected according to catalog quality, cohort data, phenotype design, and whether the goal is discovery, association, candidate prioritization, or marker conversion.

Build a Population Genotype Matrix from the Available SV Evidence

The genotyping route is selected by event class and available evidence, not by one universal caller. Deletions may be supported by depth and junction evidence; insertions need alternate-sequence or graph representation; inversions depend on breakpoint orientation; duplications and CNVs require copy-state modeling; complex or multi-allelic loci may need local assembly or targeted confirmation.

1. Freeze the catalog and population question

Define the reference build, event identities, phenotype endpoints, population groups, covariates, relatedness information, and which SV classes are in scope.

2. Match each event to observable evidence

Record whether paired-end, split-read, read-depth, local-assembly, graph-mapping, long-read, or targeted-junction evidence can distinguish reference, alternate, and copy states.

3. Re-genotype the full cohort

Use consistent references and versioned parameters across samples; preserve genotype quality, read support, copy-state evidence, and no-call reasons instead of retaining only final labels.

4. Reconcile platforms and batches

Compare shared controls or bridge samples, stratify QC by platform and batch, and avoid treating unmeasured events as biological absences.

5. Release the analyzable event set

Apply event-specific callability, frequency, missingness, concordance, subgroup, and Hardy-Weinberg or segregation review where biologically appropriate.

Choose the least complex route that can answer the question

  • Existing short reads: suitable when the catalog is sequence-resolved and event evidence can be recovered reliably across the cohort.
  • Graph or pan-genome mapping: useful when non-reference alleles and reference bias limit linear mapping, especially for insertions and presence/absence variation.
  • Population long reads: considered when complex regions, multi-allelic events, phasing, or breakpoint resolution cannot be supported by short reads.
  • Targeted re-genotyping: useful for a defined event panel, independent confirmation, or later marker conversion when stable junctions or copy states are assayable.

Population structural variant genotyping routes using short reads, graph mapping, long reads, and targeted confirmation

CD Genomics can connect Plant Pan-genome Sequencing, Long-Read Data Analysis, Targeted Sequencing, and Custom PCR Services to the population analysis plan when the evidence requires them.

How SV Genotyping, Association, and Validation Work

The workflow first separates technical callability from true population variation, then tests trait association with population controls, and finally ranks candidates by statistical, genomic, and assay-design evidence.

Step 1: Separate Callability Failures from Biological Rarity

A rare genotype and an uncallable genotype are not the same. Before association, quality review asks whether reference and alternate alleles were both measurable in each sample, whether error concentrates by SV class or genomic context, and whether missingness tracks phenotype, population, platform, or batch.

Structural variant quality controls separating supported genotypes, biological rarity, batch effects, and uncallable events

Quality gates before an SV enters association

  • Event gate: breakpoint, allele, class, reference, and multi-allelic representation remain consistent.
  • Evidence gate: read or assay support distinguishes reference, alternate, copy-state, and no-call outcomes.
  • Sample gate: identity, coverage, contamination, duplicates, relatedness, and global SV burden are reviewed.
  • Population gate: frequency, subgroup distribution, missingness, batch, platform, and phenotype-related callability are tested.
  • Concordance gate: replicates, pedigrees, assemblies, long-read controls, or targeted assays challenge selected calls.

What happens to an uneven event?

It may be retained with an explicit no-call state, analyzed only in a supported subgroup, re-genotyped by another route, collapsed to a biologically justified copy-state model, moved to a burden or region-level test, or excluded. The choice is documented before association so technical absence is not mistaken for the reference allele.

Step 2: Test SV Effects with Population Context

Association models are selected after the analyzable event set and phenotype model are defined. The analysis controls structure and relatedness, examines allele count and subgroup support, and distinguishes a direct SV test from evidence that an SV merely tags a nearby SNP haplotype.

SV-only association

Question: Which supported SV genotypes are associated with the trait?

Evidence: effect direction, uncertainty, allele frequency, model diagnostics, and local context.

Boundary: statistical association does not establish causality or assay transferability.

Combined SNP + SV analysis

Question: Does the SV explain signal not captured by nearby SNPs or improve the local genetic model?

Evidence: conditional models, local linkage disequilibrium, joint tests, and comparison of regional signals.

Boundary: correlated variants may remain statistically inseparable without recombination or functional evidence.

Rare or grouped-event tests

Question: Can low-frequency events be evaluated at a gene, region, or functional category level?

Evidence: burden or grouped-event statistics with direction and grouping rules stated.

Boundary: grouping unlike mechanisms can obscure rather than increase biological meaning.

Environment and subgroup review

Question: Is the signal consistent across environments, years, sexes, breeds, germplasm groups, or management conditions?

Evidence: stratified estimates, interaction tests, sensitivity analyses, and heterogeneity review.

Boundary: subgroup findings require adequate representation and independent confirmation.

Phenotype preparation, kinship, population structure, covariate selection, and multiple testing are planned with the same care as SV genotyping. Broader statistical support can be coordinated through Association Mapping and Agricultural Genomic Data Analysis.

Step 3: Prioritize Candidates for Validation and Marker Conversion

The most useful candidate is not always the smallest P value. We rank events by statistical support, genotype reliability, allele frequency, effect direction, local SNP dependence, gene or regulatory context, evidence across environments or populations, and whether the allele can be tested independently.

Tier 1: Association-ready evidence

The event passes population QC, has an interpretable genotype model, sufficient allele support, stable effect direction, and a regional signal that survives the agreed sensitivity checks.

Tier 2: Biological and regional context

The SV overlaps or plausibly alters gene sequence, dosage, promoter, enhancer, repeat, or chromosome organization, while nearby SNP and haplotype evidence is evaluated rather than ignored.

Tier 3: Orthogonal validation

Selected events are challenged with breakpoint PCR, targeted sequencing, long reads, copy-number assays, segregation, expression, or an independent population as appropriate to the event and question.

Tier 4: Marker-conversion decision

Primer or probe context, sequence uniqueness, allele complexity, flanking polymorphism, expected throughput, controls, and target population determine whether a routine assay is feasible.

Evidence labels remain explicit

  • Measured: sequencing, depth, breakpoint, copy-state, or targeted-assay evidence.
  • Associated: a statistical relationship with phenotype under a stated model.
  • Replicated: direction and signal supported in another environment, cohort, family, or assay.
  • Functionally supported: independent molecular or experimental evidence links the event to a biological effect.

Association can justify prioritization, but it is not relabeled as functional validation.

Deliverables for SV Association and Breeding Follow-Up

The delivery package keeps event identity, genotype evidence, QC, association, and candidate decisions connected so the next team can audit why an SV advanced or stopped.

Harmonized SV catalog

Stable event IDs, reference build, coordinates, type, allele sequence or copy-state definition, source records, merge rules, and ambiguity flags.

Population genotype matrix

Supported genotypes for DEL, INS, DUP, INV, CNV, or presence/absence events with genotype evidence, no-call states, and release filters retained where applicable.

Callability and frequency evidence

Event- and sample-level missingness, frequency, class, size, genomic context, coverage, batch, platform, subgroup, and concordance summaries.

Association evidence

SV-only and selected SNP+SV models, effect direction, uncertainty, model diagnostics, population controls, local LD or conditional evidence, and sensitivity results.

Candidate SV shortlist

Ranked events with trait evidence, local annotation, nearby SNP context, subgroup or environment support, unresolved alternatives, and evidence-level labels.

Validation and conversion plan

Recommended breakpoint, copy-number, targeted-sequencing, expression, segregation, replication, or marker-assay follow-up with feasibility risks stated.

Published Research Case: SV-GWAS Reveals Tomato Flavor Signals Missed by SNPs

Li, N., He, Q., Wang, J., et al. (2023). Super-pangenome analyses highlight genomic diversity and structural variation across wild and cultivated tomato species. Nature Genetics, 55, 852–860. DOI: 10.1038/s41588-023-01340-y.

Research question

Could a graph-based tomato super-pangenome make structural variants genotypable across a diverse population and reveal trait associations that conventional SNP analysis did not capture?

Study design

The researchers integrated SVs from cultivated and wild tomato genomes into a graph representation, genotyped the events across 321 accessions, and compared SV-based and SNP-based association results for flavor compounds and fruit metabolites.

Key findings

The study found that only a small fraction of association regions were shared between SV and SNP analyses, while a meaningful subset was detected only with SV genotypes. One SV-only signal involved a deletion associated with variation in a tomato flavor volatile. The result demonstrates why population re-genotyping and combined regional interpretation can recover candidate evidence that a SNP-only analysis may miss.

Why it matters for this Solution

  • The catalog was converted into genotypes for an actual population, not left as an assembly comparison.
  • A graph representation addressed non-reference alleles and supported cohort-scale calling.
  • SV and SNP association evidence were compared within the same trait context.
  • SV-only regional signals became candidates for fine mapping and marker development.

What this study does not prove

Association does not by itself establish that an SV is causal. The findings depend on the studied accessions, allele frequencies, phenotypes, graph, genotyping rules, and statistical models; low-frequency alleles and local linkage can still limit interpretation. Independent validation remains necessary before marker deployment.

Tomato super-pangenome case linking graph-based SV genotyping, flavor phenotypes, SV and SNP association, and candidate validation Illustration: original conceptual summary based on the cited study. Not a reproduction of the published figure.

What Can Enter an SV Association Project?

Projects can begin with an existing SV catalog, raw sequencing data, population genotypes, or biological material for a new route. Exact DNA and tissue requirements are confirmed after the species, SV classes, platform, event count, and validation strategy are reviewed.

Existing SV and sequence data

  • SV VCF, BEDPE, CNV tables, assembly comparisons, or graph resources
  • FASTQ, BAM/CRAM, long-read alignments, assemblies, or local contigs
  • Reference genome, alternate assemblies, annotation, and version records
  • Caller names, parameters, filters, evidence fields, and source sample IDs

Population and phenotype information

  • Sample manifest, accession, breed, family, pedigree, or cross relationships
  • Trait measurements, units, environments, years, sites, replicates, and covariates
  • Population structure, kinship, SNP genotypes, or prior GWAS results
  • Platform, library, batch, coverage, and sample-level quality metadata

DNA or biological samples

  • Plant or animal genomic DNA for the selected sequencing or targeted route
  • Species-appropriate tissue after extraction feasibility is confirmed
  • Parents, segregating progeny, reference accessions, controls, and replicates
  • Independent population or validation material when available

Information that changes the route

Tell us whether the catalog contains exact inserted alleles or approximate breakpoints, whether all samples share one sequencing platform, whether raw reads are available, whether SNP genotypes and kinship already exist, which phenotypes have repeated measurements, and whether the end goal is discovery, replication, functional follow-up, or a routine marker assay.

Why CD Genomics

  • Connected discovery and follow-up routes: pan-genome, long-read, short-read, targeted sequencing, and PCR capabilities can be scoped around the SV evidence gap.
  • Population analysis with provenance: event harmonization, genotype evidence, QC, structure, relatedness, and association models remain linked to their reference and data versions.
  • Decision-oriented handoff: candidates are separated into association evidence, replication needs, functional questions, and assay-conversion feasibility.

FAQ

1) Can we start from an existing SV VCF? ▼
Yes. The first review checks genome build, breakpoint and allele definition, source samples, callers, filters, genotyping evidence, and whether the records can be recognized consistently in the full population. A discovery VCF may require harmonization or breakpoint refinement before association.
2) Do all population samples need long-read sequencing? ▼
Not necessarily. Long-read assemblies or representative long-read samples can define events, while existing short reads, graph mapping, or targeted assays may support population re-genotyping. The route depends on SV class, allele sequence, genomic context, cohort data, and the required confidence.
3) Which SV types can be analyzed? ▼
Deletions, insertions, duplications, inversions, copy-number variants, and presence/absence events can be considered. Complex or multi-allelic loci may need a different genotype representation, local assembly, copy-state model, or targeted validation rather than a simple biallelic call.
4) Can SVs and SNPs be tested together? ▼
Yes. A combined analysis can compare regional signals, test conditioning on nearby SNPs or SVs, and determine whether the SV adds information beyond the local haplotype. Correlated variants may still remain statistically inseparable without recombination or independent functional evidence.
5) How many samples are required for SV-GWAS? ▼
There is no universal number. Power depends on allele frequency, effect size, phenotype quality, population structure, relatedness, missingness, callability, trait model, and the number of tests. We review these factors before recommending a full cohort, pilot, targeted panel, family design, or grouped-event analysis.
6) What if an SV is absent from many samples? ▼
The analysis first distinguishes a true reference genotype from an uncallable sample. Missingness is reviewed by event class, platform, batch, subgroup, phenotype, coverage, and sequence context. Unsupported events may be re-genotyped, stratified, retained as no-call, grouped, or excluded.
7) Does a significant SV become a breeding marker immediately? ▼
No. The event should be independently confirmed, evaluated against nearby SNP and haplotype evidence, tested for replication or segregation where possible, and reviewed for stable assayable sequence. Marker conversion also requires specificity, controls, and performance testing in the intended population.

Discuss Your Structural Variant Association Project

Start with the species, population, phenotype, current SV resource, available reads or samples, and the decision the candidate list must support. We will map those inputs to catalog refinement, population re-genotyping, association, validation, or marker conversion.

  • Species, reference build, assemblies, and SV catalog source
  • Population design, sample count, structure, pedigree, and relatedness
  • Phenotypes, environments, years, covariates, and data completeness
  • Available short reads, long reads, genotypes, DNA, or tissue
  • Target SV classes and intended validation or breeding follow-up
Discuss Your Project See What We Can Analyze

For a broader variation-resource workflow, see Pan-Genome Analysis. For a conventional SNP-centered trait study, see GWAS Services.

References

Mahmoud, M., Gobet, N., Cruz-Dávalos, D. I., Mounier, N., Dessimoz, C., & Sedlazeck, F. J. (2019). Structural variant calling: the long and the short of it. Genome Biology, 20, 246. DOI: 10.1186/s13059-019-1828-7.

Ho, S. S., Urban, A. E., & Mills, R. E. (2020). Structural variation in the sequencing era. Nature Reviews Genetics, 21, 171–189. DOI: 10.1038/s41576-019-0180-9.

Alonge, M., Wang, X., Benoit, M., et al. (2020). Major impacts of widespread structural variation on gene expression and crop improvement in tomato. Cell, 182(1), 145–161.e23. DOI: 10.1016/j.cell.2020.05.021.

Zhou, Y., Zhang, Z., Bao, Z., et al. (2022). Graph pangenome captures missing heritability and empowers tomato breeding. Nature, 606, 527–534. DOI: 10.1038/s41586-022-04808-9.

Li, N., He, Q., Wang, J., et al. (2023). Super-pangenome analyses highlight genomic diversity and structural variation across wild and cultivated tomato species. Nature Genetics, 55, 852–860. DOI: 10.1038/s41588-023-01340-y.

All products and services are For Research Use Only and not for diagnostic or therapeutic use.

For research purposes only, not intended for clinical diagnosis, treatment, or individual health assessments.

Send a MessageSend a Message

For any general inquiries, please fill out the form below.

For research purposes only, not intended for clinical diagnosis, treatment, or individual health assessments.